Prologue Journal

Genmab to Boost Oncology Portfolio With ProfoundBio Buy

• prologu5
• 04/03/202404/03/2024

Wall Street Journal

Danish biotech Genmab will buy U.S.-based ProfoundBio for $1.8 billion in cash as it looks to bolster its pipeline of cancer treatments.

https://www.wsj.com/articles/genmab-strengthens-oncology-portfolio-with-1-8-bln-acquisition-of-profoundbio-b121c371